A genetic approach to understanding tumor angiogenesis.
Benezra
R
R
Department of Cell Biology, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA.
de Candia
P
P
Li
H
H
Romero
E
E
Lyden
D
D
Rafii
S
S
Ruzinova
M
M
D000818:Animals; D004730:Endothelium, Vascular / Q000473:pathology; D018390:Gene Targeting; D006412:Hematopoietic Stem Cells / Q000473:pathology; D006801:Humans; D051798:Inhibitor of Differentiation Protein 1; D051796:Inhibitor of Differentiation Proteins; D051379:Mice; D018345:Mice, Knockout; D008957:Models, Genetic; D009363:Neoplasm Proteins / Q000235:genetics* / Q000502:physiology; D009369:Neoplasms / Q000098:blood supply / Q000235:genetics / Q000628:therapy; D009374:Neoplasms, Experimental / Q000098:blood supply* / Q000235:genetics*; D009389:Neovascularization, Pathologic / Q000235:genetics*; D012097:Repressor Proteins; D014157:Transcription Factors / Q000235:genetics* / Q000502:physiology; D040281:Vascular Endothelial Growth Factor Receptor-1 / Q000502:physiology; D040301:Vascular Endothelial Growth Factor Receptor-2 / Q000502:physiology
C497453:ID1 protein, human; C497455:Idb1 protein, mouse; D051798:Inhibitor of Differentiation Protein 1; D051796:Inhibitor of Differentiation Proteins; D009363:Neoplasm Proteins; D012097:Repressor Proteins; D014157:Transcription Factors; C075640:ID3 protein, human; D040281:Vascular Endothelial Growth Factor Receptor-1; D040301:Vascular Endothelial Growth Factor Receptor-2